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Background: Asthma is associated with allergic sensitization in about half of all cases, and asthma phenotypes can
vary by age and sex. DNA methylation in the promoter of the allergy regulatory gene interferon gamma (IFNγ) has
been linked to the maintenance of allergic immune function in human cell and mouse models. We hypothesized
that IFNγ promoter methylation at two well-studied, key cytosine phosphate guanine (CpG) sites (−186 and −54),
may differ by age, sex, and airway versus systemic tissue in a cohort of 74 allergic asthmatics.
Results: After sampling buccal cells, a surrogate for airway epithelial cells, and CD4+ lymphocytes, we found that
CD4+ lymphocyte methylation was significantly higher in children compared to adults at both CpG sites (P <0.01).
Buccal cell methylation was significantly higher in children at CpG −186 (P = 0.03) but not CpG −54 (P = 0.66). Methylation
was higher in males compared to females at both CpG sites in CD4+ lymphocytes (−186: P <0.01, −54: P = 0.02) but not
buccal cells (−186: P = 0.14, −54: P = 0.60). In addition, methylation was lower in CD4+ lymphocytes compared to buccal
cells (P <0.01) and neighboring CpG sites were strongly correlated in CD4+ lymphocytes (r = 0.84, P <0.01) and weakly
correlated in buccal cells (r = 0.24, P = 0.04). At CpG −186, there was significant correlation between CD4+ lymphocytes
and buccal cells (r = 0.24, P = 0.04) but not at CpG −54 (r = −0.03, P = 0.78).
Conclusions: These findings highlight significant age, sex, and tissue-related differences in IFNγ promoter methylation
that further our understanding of methylation in the allergic asthma pathway and in the application of biomarkers in
clinical research.
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Asthma is an environmentally triggered disease that is
linked to allergic sensitization in approximately 40 to 60%
of cases [1]. Critical to the development of allergic asthma
is the differentiation and maintenance of T helper (Th)
cells with a Th2 instead of a Th1 cytokine profile and their
suppression by the action of T regulatory (Treg) cells
[2-4]. The Th1 cytokine interferon gamma (IFNγ) is key
to this counter-regulation and has been shown to be
epigenetically regulated. For example, in vivo IFNγ gene* Correspondence: sl3230@cumc.columbia.edu
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article, unless otherwise stated.expression is reduced in CD4+ T cells of asthmatics versus
non-asthmatics [5]. Several studies to date have demon-
strated altered methylation in the promoter region of the
IFNγ gene as a mechanism for silencing or inducing Th1
polarization and/or differentiation [6-11] in both murine
(cytosine phosphate guanine (CpG) −34, −45, −53) [12]
and human (CpGs −53, −186) cells [13].
Emerging evidence suggests that environmental triggers
for allergic asthma can alter DNA methylation in the IFNγ
gene promoter and thereby modify asthma risk [14,15].
Two recent murine studies demonstrated that fungal aller-
gen [14] and ovalbumin (OVA) [15] sensitization, models
of allergic disease, increased IFNγ promoter methylation
in splenic CD4+ T lymphocytes. Hypermethylation ofCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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globulin E (IgE) [14] and associated with protection from
allergic inflammation and reduction in airway hyperreac-
tivity in experimental versus control mice [15]. This rela-
tionship was investigated further both in vitro and in
human cell experiments by Tang et al. [16]. Jurkat T cells
were exposed to the environmental air pollutant polycyclic
aromatic hydrocarbon (PAH) and demonstrated enhanced
IFNγ promoter DNA methylation and diminished gene
expression. Furthermore, in human umbilical cord white
blood cells, IFNγ promoter methylation was higher in
children with higher measures of prenatal PAH exposure
compared to lower ones, measured by personal monitor-
ing for 48 hours during pregnancy [16]. IFNγ methylation
also has been shown to vary by asthma diagnosis among
monozygotic twins consistent with mediation by environ-
mental exposure [5].
DNA methylation is dynamic [17-19]. Though global
methylation appears to increase over time [20], studies
by both Melvin et al. and White et al. demonstrated that
IFNγ T cell methylation appears to decrease in adults
compared to neonates [21,22]. These relationships, how-
ever, have not been previously explored in a population of
allergic asthmatics. Similarly, DNA methylation has been
shown to vary by sex [23,24], though these differences
have not been well-characterized, particularly those relating
to asthma regulatory genes. Moreover, asthma is charac-
terized by a male predominance in childhood and female
predominance in adulthood [25,26], a relationship that
could be linked to age and sex-related variation in DNA
methylation.
Finally, differences in gene expression across tissues
have been shown to be important in asthma. For example,
in a small cohort of 25 children with and without atopic
asthma, Stefanowicz et al. [27] demonstrated 80 CpG sites
across 67 genes that were differentially methylated in
peripheral blood mononuclear cells (PBMCs) compared
with airway epithelial cells (AECs) [27], suggesting each
cell type has its own unique methylation signature.
Similarly, in a newborn twin cohort in which cord blood
mononuclear cells and granulocytes, human umbilical
vein endothelial cells, buccal cells, and placental tissue
was obtained, varying patterns of methylation were noted
between tissue types in the insulin growth factor 2 (IGF2)
and H19 gene loci [28]. Both systemic and target tissue-
specific biomarkers are utilized in asthma research, thus a
better understanding of methylation differences in varying
cell types is critical as we explore appropriate biomarkers
for epigenetic asthma research.
We hypothesized age and sex-related differences exist
in DNA methylation of the allergy counter-regulatory
gene IFNγ in a cohort of children and adults with allergic
asthma. We also hypothesized that methylation in systemic
CD4+ T lymphocytes differs from buccal cells, a lowerairway epithelial cell surrogate. We sought a biomarker
that may be suitable for wide application in pediatric
clinical research and be much less invasive than the
sampling of lower airway epithelial cells, the disease
target cells. Buccal cells, an easily accessible population of
neighboring tissue that encompasses a portion of the
upper airway, have been previously proposed as a surro-
gate [29,30]. In this current study we sought to compare
DNA methylation levels at highly conserved (between
human and mouse) CpG sites in the IFNγ gene promoter
region (CpG −186 and −54, Figure 1) between CD4+ T
lymphocytes and buccal cells in a select cohort of allergic-
sensitized children and adults with asthma. CpGs −186
and −54 also were selected because of their association
with environmental exposure and allergic outcomes in
animal studies [14,15], as well as with asthma outcomes in
human studies [5,31].
Results
Variation in methylation levels by age and sex
In order to identify age- and sex-related patterns of IFNγ
promoter methylation in a cohort of allergic asthmatics
CD4+ lymphocytes and buccal cells (matched pairs)
were collected from 27 children and 47 adults. A total
of 60% of the adults were diagnosed with asthma in
childhood by the age of 12 years. The methylation of
CD4+ lymphocytes was higher in children compared
with adults at both CpG −186 (P <0.01) and CpG −54
(P <0.01). The methylation of buccal cell DNA was also
higher in children compared with adults at CpG −186
(P = 0.03) but not at CpG −54 (P = 0.66) (Figure 2). The
methylation of CD4+ lymphocytes was higher in males
compared with females at both CpG −186 (P <0.01) and
CpG −54 (P = 0.02), however there was no significant
sex-related difference in buccal cell methylation (CpG −186:
P = 0.14, CpG −54: P = 0.60) (Figure 3).
In a multivariable regression model both age and sex
were significant predictors of IFNγ CpG −186 methyla-
tion (P <0.01) in CD4+ lymphocytes. Sex (n = 31 males,
n = 43 females) was a significant modifier of the effect of
age on methylation in CpG −186. As age in males increased
by one year absolute CD4+ lymphocyte methylation de-
creased by 0.52%, whereas as age in females increased
by one year absolute methylation decreased by 0.28%.
Age was also a significant predictor of methylation in
CpG −54, although there was no significant interaction
by sex.
Comparison of methylation levels between CD4+
lymphocyte and buccal cells
As DNA methylation in different tissue types can vary
and appropriate biomarkers for epigenetic asthma research
are needed, we sought to determine the relationship be-
tween CD4+ lymphocyte and buccal cell IFNγ promoter
Figure 1 Schematic diagram of the location of CpG sites targeted in the promoter region of the IFNγ gene. CpG −54 corresponds to the
murine counterpart CpG −53. Methylation levels at CpGs −54 and −186 have been shown to be mediated by environmental exposures and in
association with allergic outcomes in animal models [14,15] and asthma in human studies [5,31]. CpG −295 is not conserved between mice
and humans.
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level was lower in CD4+ lymphocytes compared with
buccal cells at both IFNγ promoter CpG −186 (P <0.01)
and CpG −54 (P <0.01). Significant correlation was
observed between CD4+ lymphocyte and buccal cell
methylation at CpG −186 (r = 0.24, P = 0.04) (Figure 4).
However, there was no correlation in methylation between
the differing cell types at CpG −54 (r = −0.03, P = 0.78).
When the data were stratified by age group, correlations
were not detected at CpG −186 (children: r = 0.19, P = 0.34;
adults: r = −0.15, P = 0.31) nor CpG −54 (children: r = 0.16,
P = 0.42; adults: r = −0.04, P = 0.77). When the data were
stratified by sex, correlation was detected between differing
cell types in males at CpG −186 (r = 0.42, P = -0.02) but
not CpG −54 (r = 0.04, P = 0.84). No correlation wasFigure 2 Comparison of IFNγ promoter methylation levels by tissue t
≥18 years, n = 47. Children had significantly higher CD4+ methylation level
buccal cells was also significantly higher in children compared with adultsdetected between differing cells in females (CpG −186:
r = 0.06, P = 0.69; CpG −54: r = −0.1, P = 0.54).
Comparison of methylation levels between CpG sites by
cell type
In order to explore relationships between neighboring CpG
sites in different tissue types we compared methylation of
the two IFNγ promoter CpG sites in CD4+ lymphocytes
and buccal cells. DNA methylation correlated highly be-
tween CpG −186 and −54 in CD4+ lymphocytes (r = 0.84,
P <0.01), but weakly in buccal cells (r = 0.24, P = 0.04).
When stratified by age group, the strong correlation
between CpG sites in CD4+ lymphocytes remained in
both strata (children: r = 0.88, P <0.01; adults: r = 0.63,
P <0.01). A significant correlation emerged betweenype and CpG site stratified by age. Children <18 years, n = 27, adults
s at both CpG sites (−186 and −54: P <0.01). The methylation level of
at CpG −186 (P = 0.03) but not CpG −54 (P = 0.66).
Figure 3 Comparison of IFNγ promoter methylation levels by tissue type and CpG site stratified by sex. n = 31 males, n = 43 females.
Males had significantly higher CD4+ methylation levels at both CpG sites (−186: P < 0.01, −54: P = 0.02), however, sex-specific differences were not
identified in buccal cells (−186: P = 0.14, −54: P = 0.60).
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not in child buccal cells (r = −0.14, P = 0.49).
Comparison of methylation and gene expression
DNA methylation in the promoter region of IFNγ has
been negatively correlated with RNA gene expression
in vitro [16] and in vivo [31]. Thus we sought to validate
this finding in our cohort of allergic asthmatics. RNA
was analyzed for gene expression in 24 children and 44
adults (missing data n = 6) Relative IFNγ gene expression,Figure 4 Relationship between IFNγ promoter methylation at neighb
children (clear dots) and n = 47 adults (filled dots). The methylation level w
lymphocytes (r = 0.84, P <0.01) and weakly correlated across neighboring Cnormalized to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) gene expression using the 2ΔCt method, nega-
tively correlated with CD4+ lymphocyte methylation at
CpG −186 (r = −0.38, P <0.01) and CpG −54 (r = −0.28,
P = 0.02).
Discussion
We have demonstrated that in a cohort of children and
adults with allergic asthma, age and sex are important
predictors of IFNγ promoter DNA methylation. IFNγoring CpG sites (−186 and −54) stratified by cell type. n = 27
as highly correlated between neighboring CpG sites in CD4+
pG sites in buccal cells (r = 0.24, P = 0.04).
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cytes and buccal cells of children compared with adults,
and higher in males compared with females in CD4+ lym-
phocytes but not buccal cells. IFNγ promoter methylation
also behaved differently between tissue types. Methylation
levels were lower in CD4+ lymphocytes compared to buc-
cal cells, methylation between the two tissue types did not
correlate, and neighboring CpG methylation correlated in
CD4+ lymphocytes but not in buccal cells. These findings
underscore the importance of age- and sex-related differ-
ences in IFNγ promoter methylation, a phenomenon that
likely also exists in other asthma regulatory genes but
is understudied. In addition, our findings highlight the
significance of varying methylation patterns in different
tissue types, and we present an example of the concept
that neighboring CpG sites behave differently in differing
tissues. This knowledge is integral in developing appropri-
ate biomarkers for epigenetic asthma research.
Asthma prevalence is known to vary by age and sex
such that in early childhood males are more likely to have
asthma symptoms than females, while this relationship
seems to reverse in adolescents resulting in more female
adult asthma [25,26]. In our study population 60% of the
adults were diagnosed with asthma in childhood, therefore
the differences we observed are unlikely to be due to
phenotypic differences related to childhood versus
adult onset asthma. In a cohort of asthmatics and non-
asthmatics, Naumova et al. [23] reported lower mean
methylation levels in males compared with females, as
well as slight increases in methylation with age in the
zona pellucida binding protein 2 (ZPBP2) promoter, a
gene found in the 17q12-q21 chromosome region that
has been linked to childhood onset of asthma. Although
the direction of the sex- and age-specific methylation
differences in ZPBP2 is opposite to that of IFNγ, both
our and the Naumova studies highlight the significance
of age and sex in DNA methylation that may modify
genetic effects in diseases like asthma. It is plausible that
the epidemiologic variation in asthma prevalence may
be attributable to varying DNA methylation patterns with
sex and age. Support for the former case can be derived
from prior studies in rats and mice that showed estrogen
hormone administration altered DNA methylation and
the gene expression of multiple genes in several organs
[32,33]. Therefore it can be postulated that hormone-
related changes with puberty may alter DNA methylation
and histone modification patterns in asthma genes like
IFNγ, thus increasing or decreasing the risk of diseases
like asthma [34]. In this current study design we did not
have power to assess sex-related methylation differences
in child versus adult age groups, however, this is an im-
portant area for future research.
Biomarkers from both systemic (IgE, periostin, and cir-
culating eosinophils) and airway (fractional exhaled nitricoxide (FeNO) and sputum eosinophils) sources are
used in asthma research, especially among those with
the allergic phenotype. However it is unclear which is
superior in terms of accessibility and prediction of disease
progression. Therefore in developing novel epigenetic bio-
markers in asthma, it is critical that we distinguish key
epigenetic differences in systemic versus airway tissues.
Similar to Stefanowicz et al. who identified differential
patterns of methylation in PBMCs and airway epithelial
cells by microarray [27], using a different technique we
too found methylation varied between systemic cells, CD4
+ lymphocytes, and airway surrogates (buccal cells). Our
approach was to focus on the allergic asthma counter-
regulatory IFNγ gene promoter, susceptible to epigenetic
regulation following environmental exposures [16], and
due to the more sensitive approach of pyrosequencing we
identified cell/tissue specific methylation differences in a
gene not previously reported by Stefanowicz et al. The
strong correlations between CpGs −186 and −54 in CD4+
lymphocytes and weaker correlations between the same
sites in buccal cells reported here also highlight the vary-
ing behavior of neighboring CpG methylation in different
tissues. We sampled buccal cells as they are an easily
accessible population of cells that have been proposed as
an appropriate surrogate for lower airway epithelial cells.
A strong correlation in IFNγ gene expression has been
demonstrated between buccal and lower airway epithelial
cells in adult smokers [30]. In addition, buccal cell methy-
lation levels in children in a different asthma pathway
(arginase 1 and 2 and inducible nitric oxide synthase
(iNOS)) have been associated with the airway inflamma-
tory marker FeNO [35-37], suggesting DNA methylation
in buccal cells may be clinically relevant to airway disease.
Previously, Jones and Chen suggested that because of its
rapid methylation upon stimulation, the more proximal
CpG −53 site, compared with the five other murine IFNγ
promoter CpG sites they examined, is the key CpG
involved in the suppression of IFNγ transcription [12].
Gonsky et al. [10] replicated these findings in subjects
with inflammatory bowel disease and similarly demon-
strated methylation of the corresponding human IFNγ
CpG site −54 significantly inhibited gene expression in
PBMCs and intestinal lamina propria cells. In our allergic
asthma cohort CpG −186 emerged as an interesting site
based on the significant correlations in methylation be-
tween CD4+ lymphocytes and buccal cells at this CpG
and not −54. In addition, CpG −186 methylation was pre-
dicted by both age and sex, whereas −54 was only signifi-
cantly predicted by age and not sex in multivariable
regression models. These neighboring CpG sites appear to
behave differently in the different tissues examined given
the correlation between the two sites in CD4+ lympho-
cytes but not in buccal cells. These findings suggest there
may be a unique methylation signature that varies by
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further related back to disease phenotypes.
The link between IFNγ promoter DNA methylation
and gene expression has been explored in several
in vitro studies [12,13]. In vivo, Kohli et al. described sig-
nificant negative correlations (r = −0.75) between IFNγ
DNA methylation and the gene expression of T effector
cells of 7 to 18-year-old non-asthmatics [31]. In contrast
to the high inverse correlation in the aforementioned
study, we found significant but weak inverse correlation
between IFNγ DNA methylation and gene expression in
the CD4+ lymphocytes of adults and children with
asthma suggesting that promoter methylation is not the
only driver of IFNγ gene expression. In a study of IFNγ
methylation in cord blood mononuclear cells and adult
peripheral blood mononuclear cells, White et al. described
significant methylation in non-CpG sites (CpA and CpT
methylation) and hypothesized methylation at these sites
may enhance CpG methylation suppression of gene activity
[22]. In addition, there is an emerging body of literature on
5-hydroxymethylation [38] as well as on the significant role
of RNA polymerase in gene transcription, emphasizing the
complexity of the epigenome and indicating a more com-
plex relationship with downstream transcriptional activities.
We acknowledge that by sampling a select group of
asthmatics that were both exposed and sensitized to in-
door allergens, these findings may not be generalizable
to the population although, our goal was to understand a
key allergic regulatory gene in an allergic patient popula-
tion. IFNγ promoter methylation needs to be compared
between asthmatics and healthy controls in future studies
to further validate the importance of this region, to deter-
mine if the observed patterns are the result of the disease
state alone, and to confirm the significant age- and
sex-related differences we describe. Another limitation
of our study is that we compared DNA methylation in
buccal cells (a mixed-cell population) to CD4+ lympho-
cytes (a very select population). In our study methylation
across CpG sites was more consistent and correlated in
CD4+ lymphocytes compared with buccal cells, suggesting
methylation of the systemic CD4+ lymphocytes is more
consistent across the gene region than in the local buccal
cells. However, further studies linking methylation in
varied cell types to asthma outcomes are needed to deter-
mine the superiority of CD4+ lymphocytes versus buccal
cells as a biomarker for allergic asthma.
Conclusions
Our findings highlight significant age-, sex- and tissue-
related differences in IFNγ promoter methylation in aller-
gic asthmatics. These associations are likely present and
need to be investigated further in other asthma-related
genes. This knowledge is critical to our understanding of




Subjects were recruited for the randomized control trial
‘Comparative effectiveness of environmental intervention
and standard care in ability to reduce pharmacologic
therapy for asthma’ (American Recovery and Reinvest-
ment Act (ARRA): R01 HS019384). Inclusion criteria
were as follows: clinical diagnosis of asthma, use of con-
troller medication, reversibility of airway obstruction on
spirometry post-bronchodilator or positive methacholine
challenge, positive skin prick test or specific IgE test to
common indoor allergens (dog, cat, cockroach, dust mite,
mouse), and elevated allergen in the home dust sample.
Baseline buccal and blood samples were collected prior to
randomization to control or intervention groups. All
subjects in which both buccal and blood samples were
collected were included in the analysis (27 children and
47 adults). Informed consent and assent were obtained
from all participants prior to their participation in the
study. This study was approved by the Columbia University
Institutional Review Board.
Collection of buccal cell samples
Buccal cell samples were collected using the CytoSoft cy-
tology brush (Fischer Scientific, Pittsburgh, Pennsylvania,
United States), as published by our group [17]. Each par-
ticipant rinsed his or her mouth with water and then
brushed the inside of his or her cheeks for one minute.
The swab was then immediately placed into 600 μl of cell
lysis solution (Qiagen Sciences, Germantown, Maryland,
United States). This process was repeated five times for
each participant yielding two buccal samples each for
DNA analysis.
Collection and isolation of CD4+ lymphocytes
PBMCs were isolated from whole blood samples using the
Ficoll-Paque (GE Healthcare, Uppsala, Sweden) method.
CD4+ lymphocytes were then isolated using CD4 +
MicroBeads according to the MACS® Miltenyi Biotec
(Auburn, California, United States) protocol.
DNA extraction, quantification, and bisulfite conversion
Buccal cell and CD4+ lymphocyte DNA extractions were
performed using Puregene buccal cell core kits (Qiagen
Sciences, Germantown, Maryland, United States) according
to the manufacturer’s instructions, except all centrifugations
were conducted at 4°C instead of room temperature. The
two buccal samples obtained from each participant were
combined after individual extraction. Extracted DNA was
quantified using a NanoDrop spectrophotometer (Thermo
Scientific, Wilmington, Delaware, United States). Bisulfite
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cell and CD4+ lymphocyte DNA using Zymo Research’s
EZ DNA methylation kit (Irvine, California, United States)
and the manufacturer’s instructions. Samples were in-
cubated under the alternative incubation conditions for
Illumina Infinium methylation assay (San Diego, California,
United States) with an increased number of cycles (20
cycles of 95°C for 30 seconds and 50°C for 15 minutes)
[17,39].
PCR amplification and pyrosequencing
The primers for performing PCR and the PCR product
sequencing (Table 1) were designed using PyroMark Assay
Design 2.0 software (Qiagen, Valencia, California, United
States) for the regions of interest: IFNγ CpG −54 and −186.
These targeted areas were chosen based on previous studies
from our group and others that demonstrate change in
methylation associated with allergic outcomes and asthma
diagnosis [5,14,15,31]. PCR reactions were performed with
Qiagen Hot Star Taq DNA polymerase reagents (Qiagen
Sciences, Germantown, Maryland, United States) with the
following concentrations for each ingredient in the PCR
mixtures: 1 × PCR buffer, 0.5 μM deoxynucleotide triphos-
phates (dNTP), 0.5 μM forward primer, 0.5 μM reverse
primer and parameters highlighted in Table 1. The PCR
product was sequenced using a PyroMark Q24 pyrosequen-
cer after verifying the positive PCR products by visualizing
the appropriately sized band on a 1.2% agarose gel. EpiTect
high and low methylated control DNA (Qiagen Sciences,
Germantown, Maryland, United States) were included with
every pyrosequencing experiment. Batches were repeated if
high methylation control was <85% methylated (mean
93.5%, SD 4.3) and low methylation control was >10%
methylated (mean 3.8%, SD 1.8). Replicate pyrosequencing
results for n = 11 matched CD4+ lymphocyte and buccal
samples yielded good concordance correlation (CD4+ cells
rc = 0.93, buccal cells rc = 0.94).Table 1 Primers and amplification conditions for PCR, pyrose
Gene/region Assay Primers
IFNγ promoter CpG −186 PCR and Pyrosequencing F: 5’-biotin-AGATG
R: 5’-TCCCACCAA
S: 5’-AAATAAACA
IFNγ promoter CpG −54 F: 5’ATGTGTTGTA
R: 5’-biotin-TATCA
S: 5’-ATTGAAGTTT
IFNγ promoter (target) RT-qPCR F: 5’-TCGGTAACT
R: 5’-TCGCTTCCCT
GAPDH (internal control) F: 5’-ACAACTTTG
R: 5’-GCCATCACG
F (forward primer), R (reverse primer), S (sequencing primer), IFNγ (interferon gamm
sec (seconds).RNA extraction and reverse transcription
RNA was extracted from isolated CD4+ lymphocytes
and stored in TriReagent (Molecular Research Center,
Cincinnati, Ohio, United States) according to the manufac-
turer’s instruction with 0.2 ml of chloroform and the
following exceptions: 0.6 ml of isopropanol was used
for RNA precipitation, 1 ml of 70% ethanol was used to
wash RNA, and all centrifugations were performed at
4°C instead of room temperature. RNA was quantified
using a NanoDrop spectrophotometer (Thermo Scientific,
Wilmington, Delaware, United States). cDNA synthesis was
performed using the SuperScript First-Strand Synthesis Sys-
tem (Life Technologies, Grand Island, New York, United
States) according to the manufacturer’s instructions.
Real-time quantitative PCR (RT-qPCR)
RT-qPCR was performed using iTaq Universal SYBR
Green Supermix (BioRad, Hercules, California, United
States) with up to 200 ng of cDNA and 1 μl of primer
pair mix on a BioRad real-time PCR system. Expression
of IFNγ (RefSeq: NM_000619) was normalized to that
of glyceraldehyde-3-phospate dehydrogenase (GAPDH)
(RefSeq: NM_001256799). The primers and conditions
used for amplification are noted in Table 1. Procedures
were performed twice per sample . Results were calculated
using the 2ΔCt relative to the control gene, GAPDH.
Statistical analysis
Spearman’s correlations were performed for the data that
were not normally distributed and Pearson’s correlations
were performed for all others. All correlations, student’s
t-tests, and linear regression models were performed
using SAS 9.4 software (Cary, North Carolina, United
States). In order to determine effect modification of
age by sex a cross product term of these two variables
was included in the multivariable linear regression
model. We adjusted for tobacco smoke exposure andquencing, and RT-qPCR experiments
PCR Conditions
GTGATAGATAGGTAGGGATGATA-3’ 95°C, 15 min; 45 cycles of 95°C,
30 sec; 55°C, 30 sec; 72°C, 30 sec;





GACTTGAATGTCCA-3’ 95°C, 3 min; 40 cycles of 90°C,




a), GAPDH (glyceraldehyde 3-phosphate dehydrogenase), min (minutes),
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dictors nor did they influence our main effects, there-
fore we eliminated these variables in our final model.
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